265 related articles for article (PubMed ID: 19486000)
1. Hydroxyisohexyl 3-cyclohexene carboxaldehyde allergy: relationship between patch test and repeated open application test thresholds.
Fischer LA; Menné T; Avnstorp C; Kasting GB; Johansen JD
Br J Dermatol; 2009 Sep; 161(3):560-7. PubMed ID: 19486000
[TBL] [Abstract][Full Text] [Related]
2. Nickel allergy: relationship between patch test and repeated open application test thresholds.
Fischer LA; Johansen JD; Menné T
Br J Dermatol; 2007 Oct; 157(4):723-9. PubMed ID: 17634081
[TBL] [Abstract][Full Text] [Related]
3. Quantitative patch and repeated open application testing in hydroxyisohexyl 3-cyclohexene carboxaldehyde sensitive-patients.
Schnuch A; Uter W; Dickel H; Szliska C; Schliemann S; Eben R; Ruëff F; Gimenez-Arnau A; Löffler H; Aberer W; Frambach Y; Worm M; Niebuhr M; Hillen U; Martin V; Jappe U; Frosch PJ; Mahler V
Contact Dermatitis; 2009 Sep; 61(3):152-62. PubMed ID: 19780773
[TBL] [Abstract][Full Text] [Related]
4. Methyldibromoglutaronitrile allergy: relationship between patch test and repeated open application test thresholds.
Fischer LA; Johansen JD; Menné T
Br J Dermatol; 2008 Nov; 159(5):1138-43. PubMed ID: 18795931
[TBL] [Abstract][Full Text] [Related]
5. Recommendation to include fragrance mix 2 and hydroxyisohexyl 3-cyclohexene carboxaldehyde (Lyral) in the European baseline patch test series.
Bruze M; Andersen KE; Goossens A; ;
Contact Dermatitis; 2008 Mar; 58(3):129-33. PubMed ID: 18279149
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyisohexyl 3-cyclohexene carboxaldehyde (Lyral®) as allergen: experience from a contact dermatitis unit.
Carvalho R; Maio P; Amaro C; Santos R; Cardoso J
Cutan Ocul Toxicol; 2011 Sep; 30(3):249-50. PubMed ID: 21345163
[TBL] [Abstract][Full Text] [Related]
7. Experimental elicitation with hydroxyisohexyl-3-cyclohexene carboxaldehyde-containing deodorants.
Jørgensen PH; Jensen CD; Rastogi S; Andersen KE; Johansen JD
Contact Dermatitis; 2007 Mar; 56(3):146-50. PubMed ID: 17295689
[TBL] [Abstract][Full Text] [Related]
8. Patch testing with hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC) - a multicentre study of the Swedish Contact Dermatitis Research Group.
Engfeldt M; Hagvall L; Isaksson M; Matura M; Mowitz M; Ryberg K; Stenberg B; Svedman C; Bruze M
Contact Dermatitis; 2017 Jan; 76(1):34-39. PubMed ID: 27767215
[TBL] [Abstract][Full Text] [Related]
9. Dose per unit area - a study of elicitation of nickel allergy.
Fischer LA; Menné T; Johansen JD
Contact Dermatitis; 2007 May; 56(5):255-61. PubMed ID: 17441846
[TBL] [Abstract][Full Text] [Related]
10. Contact Allergy to Fragrance Mix II and Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde: A Retrospective Study by International Contact Dermatitis Research Group.
Bruze M; Ale I; Andersen KE; Cannavó A; Diepgen T; Elsner P; Goh CL; Gonçalo M; Goossens A; McFadden J; Nixon R; Puangpet P; Sasseville D;
Dermatitis; 2020; 31(4):268-271. PubMed ID: 32265353
[TBL] [Abstract][Full Text] [Related]
11. Multicentre patch testing with fragrance mix II and hydroxyisohexyl 3-cyclohexene carboxaldehyde by the Swedish Contact Dermatitis Research Group.
Isaksson M; Inerot A; Lidén C; Lindberg M; Matura M; Möller H; Stenberg B; Bruze M
Contact Dermatitis; 2014 Mar; 70(3):187-9. PubMed ID: 24588374
[No Abstract] [Full Text] [Related]
12. Patch testing with a new fragrance mix - reactivity to the individual constituents and chemical detection in relevant cosmetic products.
Frosch PJ; Rastogi SC; Pirker C; Brinkmeier T; Andersen KE; Bruze M; Svedman C; Goossens A; White IR; Uter W; Arnau EG; Lepoittevin JP; Johansen JD; Menne T
Contact Dermatitis; 2005 Apr; 52(4):216-25. PubMed ID: 15859994
[TBL] [Abstract][Full Text] [Related]
13. Results of patch testing with fragrance mix 1, fragrance mix 2, and their ingredients, and Myroxylon pereirae and colophonium, over a 21-year period.
Nardelli A; Carbonez A; Drieghe J; Goossens A
Contact Dermatitis; 2013 May; 68(5):307-13. PubMed ID: 23601065
[TBL] [Abstract][Full Text] [Related]
14. Decrease of contact allergy to hydroxyisohexyl 3-cyclohexene carboxaldehyde in Europe prior to its ban and diagnostic value.
Ahlström MG; Uter W; Ahlström MG; Johansen JD
Contact Dermatitis; 2021 Jun; 84(6):419-422. PubMed ID: 33453125
[TBL] [Abstract][Full Text] [Related]
15. Risk factors associated with sensitization to hydroxyisohexyl 3-cyclohexene carboxaldehyde.
Uter W; Geier J; Schnuch A; Gefeller O
Contact Dermatitis; 2013 Aug; 69(2):72-7. PubMed ID: 23869726
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyisohexyl 3-cyclohexene carboxaldehyde (Lyral) is still a frequent allergen.
Braendstrup P; Johansen JD;
Contact Dermatitis; 2008 Sep; 59(3):187-8. PubMed ID: 18759910
[No Abstract] [Full Text] [Related]
17. The dose-response relationship between the patch test and ROAT and the potential use for regulatory purposes.
Fischer LA; Voelund A; Andersen KE; Menné T; Johansen JD
Contact Dermatitis; 2009 Oct; 61(4):201-8. PubMed ID: 19825091
[TBL] [Abstract][Full Text] [Related]
18. Quantitative patch and repeated open application testing in methyldibromo glutaronitrile-sensitive patients.
Schnuch A; Kelterer D; Bauer A; Schuster Ch; Aberer W; Mahler V; Katzer K; Rakoski J; Jappe U; Krautheim A; Bircher A; Koch P; Worm M; Löffler H; Hillen U; Frosch PJ; Uter W
Contact Dermatitis; 2005 Apr; 52(4):197-206. PubMed ID: 15859992
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyisohexyl 3-cyclohexene carboxaldehyde (lyral) in patch test preparations under varied storage conditions.
Hamann D; Hamann CR; Zimerson E; Bruze M
Dermatitis; 2013; 24(5):246-8. PubMed ID: 24030363
[TBL] [Abstract][Full Text] [Related]
20. Fragrance contact allergy: a 4-year retrospective study.
Cuesta L; Silvestre JF; Toledo F; Lucas A; Pérez-Crespo M; Ballester I
Contact Dermatitis; 2010 Aug; 63(2):77-84. PubMed ID: 20573166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
